论文信息 - Influence of tumor response on the survival of patients with extensive-stage small-cell lung cancer treated with the etoposide plus cisplatin chemotherapy regimen - 字舞流文

Influence of tumor response on the survival of patients with extensive-stage small-cell lung cancer treated with the etoposide plus cisplatin chemotherapy regimen

Chao | Long | Ying | Zhang | Lin | Guo | Yuhui | Junling | Guanzhong | Piao | Jian-fei | Xu | Liu | Han | Guojing | Co-first | Ya-ling | Yongye

[1] D. de Ruysscher,et al. Small-cell lung cancer (SCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[2] M. Lai,et al. Survival of Patients with Small Cell Lung Carcinoma in Taiwan , 2012, Oncology.

[3] J. Neal,et al. Current management of small cell lung cancer. , 2011, Clinics in chest medicine.

[4] Zhimin Zhang,et al. CEA is an Independent Prognostic Indicator that is Associated with Reduced Survival and Liver Metastases in SCLC , 2011, Cell Biochemistry and Biophysics.

[5] Tetsuya Shimizu,et al. Serum carcinoembryonic antigen level in non-small-cell lung cancer patients with preoperative normal serum level , 2009, General thoracic and cardiovascular surgery.

[6] A. Avilés-Salas,et al. Brain metastasis development and poor survival associated with carcinoembryonic antigen (CEA) level in advanced non-small cell lung cancer: a prospective analysis , 2009, BMC Cancer.

[7] Michael,et al. Small cell lung cancer: have we made any progress over the last 25 years? , 2007, The oncologist.

[8] W. Schwenk,et al. Serum vascular endothelial growth factor levels correlate better with tumour stage in small cell lung cancer than albumin, neuron‐specific enolase or lactate dehydrogenase , 2002, Respirology.

[9] N. Siafakas,et al. Prognostic Value of Serum Tumor Markers in Patients with Lung Cancer , 2002, Respiration.